BIO MED BI Biocytogen BCG036: Next-Gen PD-1/VEGF Bispecific Powered by VEGF VHH Antibody Design Asset Overview
MKT ART MU Musa Ndlala Mastering SOSL(Google BUT Salesforce Style) Basics for PD1 🎯 This deep-dive covers core SOSL concepts tested in the Platform Developer I exam(Of which I completed on 12-Aug-2025).
LIF MED BI Biocytogen PD-1 × VEGF Dual Targeting: A Potent One-Two Punch in Cancer Therapy PD-1, a critical immune checkpoint receptor on T cells, is frequently exploited by tumors to evade immune surveillance. While PD-1…
LIF BIO MED AD Aditya Rawat PD-1 and PD-L1 Explained: The Game-Changers in Cancer Immunotherapy Have you ever thought that our body is an incredible fortress, constantly working to defend us from harmful invaders like bacteria and…
EV Evalytics Labs PD-1 Immune Checkpoint Mechanism in Merkel Cell Carcinoma Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that has puzzled researchers for years. Recent studies have shed…
SPT ECO LIF MED SCI VI Vishnu Modur, PhD Blowing Hot and Cold: Unpacking Inert Inflammation In Tumors Disclaimer: The language of science is concrete, precise, and definitive. Although it is written in English, it is a distinct dialect. But…
LIF MED NA Nathan Suek Why CTLA-4 was a big deal for cancer immunotherapy CTLA-4 gets a bad rap these days. While cancer immunotherapy and checkpoint inhibitors are widely celebrated, most people like talking…